Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,387 | N/A | N/A | N/A | 12,760 |
| Receivables | 87 | N/A | N/A | N/A | 510 |
| Inventories | 17 | N/A | N/A | N/A | 250 |
| Other current assets | 0 | 0 | 0 | 0 | 190 |
| TOTAL | $30,670 | $N/A | $N/A | $N/A | $13,710 |
| Non-Current Assets | |||||
| PPE Net | 295 | N/A | N/A | N/A | N/A |
| TOTAL | $295 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $30,965 | $N/A | $N/A | $N/A | $14,250 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 866 | 0 | 0 | 0 | 1,070 |
| Accrued Expenses | 1,082 | N/A | N/A | N/A | 1,530 |
| Other current liabilities | N/A | N/A | N/A | N/A | 30 |
| TOTAL | $1,975 | $N/A | $N/A | $N/A | $2,640 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 27 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,336 | 0 | 0 | 0 | 0 |
| TOTAL | $3,430 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,405 | $N/A | $N/A | $N/A | $2,640 |
| Shareholders' Equity | |||||
| Common Shares | 3 | N/A | N/A | N/A | 3 |
| Retained earnings | -56,612 | N/A | N/A | N/A | -40,630 |
| Other shareholders' equity | 81,394 | 0 | 0 | 0 | 51,717 |
| TOTAL | $25,560 | $N/A | $N/A | $N/A | $11,600 |
| Total Liabilities And Equity | $30,965 | $0 | $0 | $0 | $14,240 |